Asset Details
Do you wish to reserve the book?
Development and validation of a risk prediction model for pulmonary tuberculosis in presumptive tuberculosis patients in Tigray, northern Ethiopia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Development and validation of a risk prediction model for pulmonary tuberculosis in presumptive tuberculosis patients in Tigray, northern Ethiopia
Do you wish to request the book?
Development and validation of a risk prediction model for pulmonary tuberculosis in presumptive tuberculosis patients in Tigray, northern Ethiopia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Development and validation of a risk prediction model for pulmonary tuberculosis in presumptive tuberculosis patients in Tigray, northern Ethiopia
2025
Overview
The incidence of tuberculosis (TB) has increased in Tigray, Ethiopia due to war and a crippled healthcare system. Although early detection and treatment are critical for TB control, over 30% of TB cases are missed using current diagnostic techniques. Thus, we developed and validated a risk prediction model for pulmonary TB in presumptive cases. In this multicenter cross-sectional study, we consecutively enrolled 907 respondents from primary healthcare facilities in Tigray, northern Ethiopia. We used least absolute shrinkage and selection operator regression to identify variables for the model. Risk scores were generated from the coefficients of multivariable logistic regression. We evaluated the model performance using the area under the curve and calibration plots, and clinical utility using decision curves. Among all respondents, 155 (17%) had GeneXpert-confirmed pulmonary TB. At an optimal cutoff value of 8.5, the model demonstrated a discrimination accuracy of 0.82 (95% CI: 0.78–0.85), a sensitivity of 82.6%, and a specificity of 68.9%. The model had a calibration slope of 0.98 and an intercept of 0.001. The model exhibits acceptable discrimination and calibration performance. Thus, it can be used for screening patients for pulmonary TB in primary healthcare settings where accurate diagnostic resources are limited.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
